The in vitro antifungal activity of compounds 1-3 ({[CH3)2NCH2]2C6H3}R:SnX; (where X=CI, R=n-Bu for 1, X=Br, R=n-Bu for 2 and x=PF6, R=n=Bu for 3)) was estimated with the help of a modified microdilution format of the M27-A guidelines and was compared with in vitro activity of their diphenyltin(IV) analogues 4 and 5 (where X=Br, R=Ph for 4 and X=PF6, R=Ph for 5), and of drugs currently in clinical use (ketoconazole, fluconazole and amphotericin B). It was found that in coordinating solvents the more soluble derivative 2 is less active than the phenyl one (4), and compounds and 3 are even inactive.
INTRODUCTION
Organotin(IV) compounds, especially triorganotin derivatives, have been extensively studied due to their potential in vitro antifungal activities against some medically important fungi/1/. Many compounds of this type display some in vitro antitumour activities against tumour cell lines of human origin/2,3/. Moreover, recently, Susperregui et al. have reported on in vivo trypanocidal activities of organotin(IV) compounds/4/.
In 1985 Atassi suggested that such in vivo antitumour activity and further clinical use of these compounds in medicine could be hampered by low water solubility/5/. A possibility to increase the water solubility of organotin compounds is to prepare compounds containing some heteroatoms in their structure/6/, or even ionic compounds. We have previously reported on such ionic compounds (water solubility ca. 200 713.4 Hz in the 31p NMR spectrum shows that the PF6 group which does not interact with the tin atom is present.
On the basis of these findings, we can conclude that the vicinity of the tin central atom is slightly distorted trigonal bipyramidal, with donor amino groups in axial and carbon atoms in equatorial positions, forming the cationic unit. The hexafluorophosphate anion is out of the primary coordination sphere of the tin atom.
In vitro antifungal activity
The results of in vitro antifungal screening for all compounds 1-5 are summarized in Table together with MIC values (minimum inhibitory concentration tmol "l) for conventional antimycotic drugs. The MICs for derivatives 4,5 were reported earlier elsewhere/7/and are only used here for comparison of antimycotic activity of their di-n-butyl analogues 1-3. The surprising discovery is that the bromobutyl derivative (2), more soluble in coordinating solvents, is less active than the phenyl one, and compounds 1 and 3 are even inactive. Table 2 and compared with IDso values of some drugs with clinical applications. In spite of the fact that both derivatives 4 and 5 display increased water solubility and promising in vitro antifungal activity/7/, Table 2 shows that both tested compounds are entirely inactive on all tumour cell lines. Table 2 in vitro inhibition doses IDs0 in ng. ml " for compounds 4 See Figure 1 . IDa0 values taken from the literature, see/3/.
